The taller you are, the more likely you may be to develop blood clots in the veins, according to new research in the American Heart Association journal Circulation: Cardiovascular Genetics.
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood.
There are various concepts about how blood cells develop. However, they are based almost exclusively on experiments that solely reflect snapshots. In a publication in Nature, scientists from the German Cancer Research Center in Heidelberg now present a novel technique that captures the process in a dynamic way.
New findings from a scientific collaboration between the German Cancer Research Centre (DKFZ), the National Centre for Tumour Diseases (NCT) Heidelberg and the Thoraxklinik Heidelberg suggest liquid biopsy as a promising tool to monitor lung cancer patient tumours early. Scientists associated liquid biopsy readouts with clinical data and could track tumour responses to cancer drugs in real-time.
The Society for Virology (GfV) which promotes virology through the increase and exchange of research within German speaking countries, as well as via cooperation with other scientific societies, announced this year that a new test can unambiguously confirm the diagnosis of a Zika virus infection – leading to fast diagnosis and identification of an infection.
Scientists from the University of Würzburg give fascinating 3D-insights into the bone marrow, and successfully elucidated new details about the process of thrombocyte generation.
Siemens Healthineers has entered into a definitive agreement to acquire Epocal Inc., a subsidiary of Alere Inc. Epocal Inc. develops and provides point-of-care blood diagnostic systems for healthcare enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution.
Teco Medical Instruments has produced coagulation analysers for a quarter of a century.
Since autumn 2016 a small tube has been making daily life easier for users and patients. A simple but effective addition now offers many new advantages in analysis, the manufacturer reports.
'Blood is a very special juice’ – something even Goethe’s Mephistopheles knew. Medics have also known this for centuries, so it’s nothing new that the ‘juice’ and its properties receive a lot of attention in medicine. However, what is new is that dealing with the use of blood through patient blood management (PBM) is coming to the fore.
Scientists have discovered that dying tumor cells release small pieces of their DNA into the bloodstream. These pieces are called circulating tumor DNA (ctDNA) or circulating cell-free DNA (ccfDNA).
Many diabetes patients must inject themselves with insulin, sometimes several times a day, while others take medications orally to control blood sugar. The injections, as well as the side effects from both regimens, can be painful. Now, one team reports in the Journal of the American Chemical Society progress toward an insulin-free diabetes treatment that requires fewer injections.
Researchers have found that people with A, B, and AB blood types may be at greater risk of cardiovascular events - particularly heart attack - than individuals with O blood types.
Genetic testing of tumor and blood fluid samples from people with and without one of the most aggressive forms of skin cancer has shown that two new blood tests can reliably detect previously unidentifiable forms of the disease.
All it takes is the flip of a protein “switch” within the tiny wire-like capillaries of the brain to increase the blood flow that ensures optimal brain function. New research has uncovered that capillaries have the capacity to both sense brain activity and generate an electrical vasodilatory signal to evoke blood flow and direct nutrients to nourish hard-working neurons.
Magnets instead of antibiotics could provide a possible new treatment method for blood infection. This involves the blood of patients being mixed with magnetic iron particles, which bind the bacteria to them after which they are removed from the blood using magnets. The initial laboratory tests at Empa in St. Gallen have been successful, and seem promising.
Pathology services in the UK are struggling to cope with the increasing number of patient samples that need to be tested, according to a Cancer Research UK report* published today.
Using specialized CT scans of a healthy heart and one with heart disease, a team of Johns Hopkins cardiologists and biomedical engineers say they've created computer models of the "shape" of blood flow through the heart's upper left chamber that someday may help predict stroke risk.
According to a 2007 World Health Organization report*, patient misidentification was cited in more than 100 individual root cause analyses (January 2000 to March 2003) by the USA’s Department of Veterans Affairs National Centre for Patient Safety. Major areas where patient misidentification can occur include drug administration, phlebotomy, blood transfusion, and surgical procedures.
EKF Diagnostics announces that its newly introduced Glycated Serum Protein (GSP) LiquiColor® diabetic biomarker test has been verified for use on the Siemens Vista chemistry analyzer. In a scientific poster published by scientists at the Memorial Healthcare System, Hollywood, USA [1], it was demonstrated that EKF’s GSP assay enhances the versatility of the Vista system for the specialized…
In a groundbreaking new study led by University of Minnesota biomedical engineers, artificial blood vessels bioengineered in the lab and implanted in young lambs are capable of growth within the recipient. If confirmed in humans, these new vessel grafts would prevent the need for repeated surgeries in some children with congenital heart defects.
The Swedish National Board of Health and Welfare recently raised the recommended target blood pressure for patients with diabetes. This may lead to more patients suffering from stroke or heart attack, according to a new study from the Sahlgrenska Academy. The new study is the world’s largest on the subject and is based on data from the National Diabetes Register.
Many cancers only become a mortal danger if they form metastases elsewhere in the body. Such secondary tumours are formed when individual cells break away from the main tumour and travel through the bloodstream to distant areas of the body. To do so, they have to pass through the walls of small blood vessels. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and…
Australian researchers have made a world-first breakthrough in the early detection of patients' resistance to a common treatment for chronic myeloid leukemia. The discovery offers some hope that the patients' treatment could be changed sooner to improve their chances of survival.
Clinicians around the world have long suspected that bacteraemia due to Staphylococcus aureus has a worse outcome in women compared to men, but direct evidence has been elusive. A study just published confirms that significantly more women than men diagnosed with Staphylococcus aureus bacteraemia (SAB) – a blood infection of the common bacteria – die within 30 days.
